{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T02:57:33Z","timestamp":1781665053419,"version":"3.54.5"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFD1800704"],"award-info":[{"award-number":["2023YFD1800704"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008970","name":"Hebei Normal University of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008970","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.vaccine.2025.127899","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T20:37:15Z","timestamp":1761683835000},"page":"127899","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Construction and evaluation of a chimeric vaccine against Clostridium perfringens type a of sika deer"],"prefix":"10.1016","volume":"68","author":[{"given":"Shengxin","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixin","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yakun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuaiyu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengqi","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoxin","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiatong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suizhong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongbo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongsheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunli","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2025.127899_bb0005","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13567-016-0336-y","article-title":"The C-terminal domain of clostridium perfringens alpha toxin as a vaccine candidate against bovine necrohemorrhagic enteritis","volume":"47","author":"Goossens","year":"2016","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2025.127899_bb0010","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12917-016-0730-8","article-title":"Toxin-neutralizing antibodies protect against clostridium perfringens-induced necrosis in an intestinal loop model for bovine necrohemorrhagic enteritis","volume":"12","author":"Goossens","year":"2016","journal-title":"BMC Vet Res"},{"key":"10.1016\/j.vaccine.2025.127899_bb0015","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/jpn.13274","article-title":"Molecular structure and function of the carboxy-terminus of the alpha-toxin from Clostridium perfringens type a","volume":"104","author":"Xu","year":"2020","journal-title":"J Anim Physiol Anim Nutr"},{"key":"10.1016\/j.vaccine.2025.127899_bb0020","doi-asserted-by":"crossref","DOI":"10.1038\/s41426-018-0144-8","article-title":"An update on the human and animal enteric pathogen Clostridium perfringens","author":"Kiu","year":"2018","journal-title":"Emerging Microbes Infections"},{"key":"10.1016\/j.vaccine.2025.127899_bb0025","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1297-9716-44-45","article-title":"The synergistic necrohemorrhagic action of clostridium perfringens perfringolysin and alpha toxin in the bovine intestine and against bovine endothelial cells","volume":"44","author":"Verherstraeten","year":"2013","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2025.127899_bb0030","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0378-1135(01)00329-7","article-title":"Bacterial intestinal flora associated with enterotoxaemia in belgian blue calves","volume":"81","author":"Manteca","year":"2001","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2025.127899_bb0035","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1136\/vr.b4869","article-title":"Enterotoxaemia-like syndrome and Clostridium perfringens in veal calves","volume":"167","author":"Muylaert","year":"2010","journal-title":"Vet Rec"},{"key":"10.1016\/j.vaccine.2025.127899_bb0040","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1016\/j.vaccine.2014.03.079","article-title":"Clostridium perfringens epsilon toxin mutant Y30A-Y196A as a recombinant vaccine candidate against enterotoxemia","volume":"32","author":"Bokori-Brown","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127899_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.vetimm.2019.109953","article-title":"Evaluation of immunogenicity and protective efficacy of a CpG-adjuvanted DNA vaccine against tembusu virus","volume":"218","author":"Chen","year":"2019","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2025.127899_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2020.104461","article-title":"Bioinformatics analysis of NetF proteins for designing a multi-epitope vaccine against clostridium perfringens infection","volume":"85","author":"Wang","year":"2020","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.vaccine.2025.127899_bb0055","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.3390\/ani14182640","article-title":"GFI-YOLOv8: sika deer posture recognition target detection method based on YOLOv8","volume":"14","author":"Gong","year":"2024","journal-title":"Animals"},{"issue":"45","key":"10.1016\/j.vaccine.2025.127899_bb0060","first-page":"13","article-title":"Diagnosis and control of Clostridium perfringens disease in prunus deer","volume":"2023","author":"Wang","year":"2023","journal-title":"Speciality Res"},{"key":"10.1016\/j.vaccine.2025.127899_bb0065","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.molimm.2020.05.006","article-title":"Immunization of mice against alpha, beta, and epsilon toxins of Clostridium perfringens using recombinant rCpa-b-x expressed by Bacillus subtilis","volume":"123","author":"Wang","year":"2020","journal-title":"Mol Immunol"},{"key":"10.1016\/j.vaccine.2025.127899_bb0070","first-page":"13","article-title":"Immunoinformatic analysis of the whole proteome for vaccine design: an application to clostridium perfringens","author":"Soto","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2025.127899_bb0075","article-title":"Design of multi-epitope chimeric phage nanocarrier vaccines for porcine deltacoronavirus","volume":"304","year":"2025","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2025.127899_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygeno.2022.110301","article-title":"An integrated in silico based subtractive genomics and reverse vaccinology approach for the identification of novel vaccine candidate and chimeric vaccine against XDR salmonella typhi H58","volume":"114","author":"Khan","year":"2022","journal-title":"Genomics"},{"key":"10.1016\/j.vaccine.2025.127899_bb0085","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.vaccine.2022.11.021","article-title":"A non-toxic recombinant bivalent chimeric protein rETXm3CSAm4\/TMD as a potential vaccine candidate against enterotoxemia and braxy","volume":"41","author":"Du","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127899_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1513245","article-title":"Designing a potent multivalent epitope vaccine candidate against orientia tsutsugamushi via reverse vaccinology technique - bioinformatics and immunoinformatic approach","volume":"16","author":"Panda","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2025.127899_bb0095","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/nar\/gkh468","article-title":"Protein structure prediction and analysis using the robetta server","volume":"32","author":"Kim","year":"2004","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.vaccine.2025.127899_bb0100","doi-asserted-by":"crossref","DOI":"10.1080\/21505594.2024.2398171","article-title":"Designing a multi-epitope subunit vaccine against orf virus using molecular docking and molecular dynamics","volume":"15","author":"Pang","year":"2024","journal-title":"Virulence"},{"key":"10.1016\/j.vaccine.2025.127899_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009862","article-title":"Computational immunology meets bioinformatics: the use of prediction tools for molecular binding in the simulation of the immune system","volume":"5","author":"Rapin","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2025.127899_bb0110","first-page":"1189","article-title":"Comparative study on the immunopotentiator effect of ISA 201, ISA 61, ISA 50, ISA 206 used in trivalent foot and mouth disease vaccine. Vet","volume":"8","author":"Ibrahim","year":"2015","journal-title":"World"},{"key":"10.1016\/j.vaccine.2025.127899_bb0115","doi-asserted-by":"crossref","first-page":"7960","DOI":"10.1016\/j.vaccine.2011.08.072","article-title":"CpG oligodeoxynucleotide and montanide ISA 206 adjuvant combination augments the immune responses of a recombinant FMDV vaccine in cattle","volume":"29","author":"Ren","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127899_bb0120","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1080\/03079457.2015.1040372","article-title":"Co-adjuvant effects of plant polysaccharide and propolis on chickens inoculated with bordetella avium inactivated vaccine","volume":"44","author":"Yang","year":"2015","journal-title":"Avian Pathol"},{"key":"10.1016\/j.vaccine.2025.127899_bb0125","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.molimm.2015.01.005","article-title":"Immunization with recombinant bivalent chimera r-cpae confers protection against alpha toxin and enterotoxin of clostridium perfringens type a in murine model","volume":"65","year":"2015","journal-title":"Mol Immunol"},{"key":"10.1016\/j.vaccine.2025.127899_bb0130","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0378-1135(02)00008-1","article-title":"A role for the clostridium perfringens \u03b22 toxin in bovine enterotoxaemia?","volume":"86","author":"Manteca","year":"2002","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2025.127899_bb0135","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1006\/anae.1999.0191","article-title":"The Clostridium perfringens a-toxin","volume":"5","author":"Titball","year":"1999","journal-title":"Anaerobe"},{"key":"10.1016\/j.vaccine.2025.127899_bb0140","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2217\/fmb.13.168","article-title":"Towards an understanding of the role of clostridium perfringens toxins in human and animal disease","volume":"9","author":"Uzal","year":"2014","journal-title":"Future Microbiol"},{"key":"10.1016\/j.vaccine.2025.127899_bb0145","doi-asserted-by":"crossref","first-page":"5217","DOI":"10.1038\/s41598-017-05567-8","article-title":"Clostridium perfringens \u03b1-toxin impairs erythropoiesis by inhibition of erythroid differentiation","volume":"7","author":"Takagishi","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2025.127899_bb0150","doi-asserted-by":"crossref","DOI":"10.1038\/srep28192","article-title":"Clostridium perfringens \u03b1-toxin impairs innate immunity via inhibition of neutrophil differentiation","volume":"6","author":"Takehara","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2025.127899_bb0155","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1128\/CMR.16.3.451-462.2003","article-title":"Biology and pathogenesis of thrombosis and Procoagulant activity in invasive infections caused by group a streptococci and Clostridium perfringens","volume":"16","author":"Bryant","year":"2003","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2025.127899_bb0160","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.pep.2014.06.014","article-title":"B-cell epitope of beta toxin of clostridium perfringens genetically conjugated to a carrier protein: expression, purification and characterization of the chimeric protein","volume":"102","author":"Bhatia","year":"2014","journal-title":"Protein Expr Purif"},{"key":"10.1016\/j.vaccine.2025.127899_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2016.05.001","article-title":"Vaccine technologies: from whole organisms to rationally designed protein assemblies","volume":"120","author":"Karch","year":"2016","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.vaccine.2025.127899_bb0170","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1186\/s12864-024-10691-7","article-title":"A novel mRNA multi-epitope vaccine of acinetobacter baumannii based on multi-target protein design in immunoinformatic approach","volume":"25","author":"Xu","year":"2024","journal-title":"BMC Genomics"},{"key":"10.1016\/j.vaccine.2025.127899_bb0175","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.3390\/vaccines12111250","article-title":"Multi-epitopic peptide vaccine against Newcastle disease virus: molecular dynamics simulation and experimental validation","volume":"12","author":"Zeb","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2025.127899_bb0180","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jviromet.2007.12.018","article-title":"Enhanced immunogenicity of multiple-epitopes of foot-and-mouth disease virus fused with porcine interferon alpha in mice and protective efficacy in guinea pigs and swine","volume":"149","author":"Du","year":"2008","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2025.127899_bb0185","doi-asserted-by":"crossref","first-page":"W180","DOI":"10.1093\/nar\/gki479","article-title":"PREDBALB\/c: a system for the prediction of peptide binding to H2d molecules, a haplotype of the BALB\/c mouse","volume":"33","author":"Zhang","year":"2005","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.vaccine.2025.127899_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113516","article-title":"The MHC-E peptide ligands for checkpoint CD94\/NKG2A are governed by inflammatory signals, whereas LILRB1\/2 receptors are peptide indifferent","volume":"42","author":"Middelburg","year":"2023","journal-title":"Cell Rep"},{"key":"10.1016\/j.vaccine.2025.127899_bb0195","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1146\/annurev.immunol.15.1.851","article-title":"H2-M3, a FULL-SERVICE CLASS ib HISTOCOMPATIBILITY ANTIGEN1","volume":"15","author":"Lindahl","year":"1997","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2025.127899_bb0200","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nprot.2016.169","article-title":"The ClusPro web server for protein\u2013protein docking","volume":"12","author":"Kozakov","year":"2017","journal-title":"Nat Protoc"},{"key":"10.1016\/j.vaccine.2025.127899_bb0205","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/90609","article-title":"Toll-like receptors: critical proteins linking innate and acquired immunity","volume":"2","author":"Akira","year":"2001","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2025.127899_bb0210","doi-asserted-by":"crossref","first-page":"33419","DOI":"10.1074\/jbc.274.47.33419","article-title":"Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products *","volume":"274","author":"Lien","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2025.127899_bb0215","first-page":"11","article-title":"Toll-like receptor 4 protects against clostridium perfringens infection in mice","author":"Takehara","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.vaccine.2025.127899_bb0220","first-page":"1843","article-title":"Compared to aluminum hydroxide adjuvant, montanide ISA 206 VG induces a higher and more durable neutralizing antibody response against FMDV in goats","volume":"78","author":"Taghizadeh","year":"2023","journal-title":"Arch Razi Inst"},{"key":"10.1016\/j.vaccine.2025.127899_bb0225","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4236\/jbm.2013.13005","article-title":"The comparison of the efficacy of swine FMD vaccine emulsified with oil adjuvant of ISA 201 VG or ISA 206 VG","volume":"01","author":"Li","year":"2013","journal-title":"JBM"},{"key":"10.1016\/j.vaccine.2025.127899_bb0230","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.vaccine.2008.11.103","article-title":"Comparison of montanide adjuvants, IMS 3012 (nanoparticle), ISA 206 and ISA 35 (emulsion based) alongwith incomplete freund\u2019s adjuvant for hyperimmunization of equines used for production of polyvalent snake antivenom","volume":"27","author":"Waghmare","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127899_bb0235","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.lwt.2019.03.020","article-title":"Quality evaluation and drying kinetics of shitake mushrooms dried by hot air, infrared and intermittent microwave\u2013assisted drying methods","volume":"107","author":"Wang","year":"2019","journal-title":"LWT"},{"key":"10.1016\/j.vaccine.2025.127899_bb0240","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1080\/21505594.2019.1582975","article-title":"Oral immunization of mice with a probiotic lactobacillus casei constitutively expressing the \u03b1-toxoid induces protective immunity against clostridium perfringens \u03b1-toxin","volume":"10","author":"Gao","year":"2019","journal-title":"Virulence"},{"key":"10.1016\/j.vaccine.2025.127899_bb0245","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.transproceed.2006.10.213","article-title":"Acute influence of FK506 on T-lymphocyte populations of peripheral blood and spleen in rats","volume":"39","author":"Wang","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1016\/j.vaccine.2025.127899_bb0250","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1749-6632.1996.tb52655.x","article-title":"IL-12-deficient mice are defective but not devoid of type 1 cytokine responses","volume":"795","author":"Magram","year":"1996","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.vaccine.2025.127899_bb0255","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1540537","article-title":"Design and development of highly conserved, HLA-promiscuous T cell multiepitope vaccines against human visceral leishmaniasis","volume":"16","author":"Barreto","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2025.127899_bb0260","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.3390\/vaccines9101058","article-title":"A T-cell epitope-based multi-epitope vaccine designed using human HLA specific T cell epitopes induces a near-sterile immunity against experimental visceral leishmaniasis in hamsters","volume":"9","author":"Arya","year":"2021","journal-title":"Vaccines"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2501196X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2501196X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T02:26:59Z","timestamp":1781663219000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X2501196X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":52,"alternative-id":["S0264410X2501196X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127899","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Construction and evaluation of a chimeric vaccine against Clostridium perfringens type a of sika deer","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127899","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"127899"}}